Abstract #2727

Myocardial fibrosis is a predictor of adverse outcomes in thalassemia intermedia patients

Antonella Meloni¹, Nicola Giunta², Pietro Giuliano², Stefania Renne³, Laura Pistoia¹, Vincenzo Positano¹, Calogera Gerardi⁴, Vincenzo Spadola⁵, Petra Keilberg¹, and Alessia Pepe¹

¹Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy, ²"ARNAS" Civico, Di Cristina Benfratelli, Palermo, Italy, ³Presidio Ospedaliero “Giovanni Paolo II”, Lamezia Terme, Italy, ⁴Presidio Ospedaliero "Giovanni Paolo II" - Distretto AG2 di Sciacca, Sciacca, Italy, ⁵Azienda Ospedaliera Civile - O.M.P.A. Ragusa, Ragusa, Italy

Myocardial fibrosis detected by LGE has been confirmed as an independent predictor of CV complications in thalassemia intermedia patients. Our finding is consistent with a growing evidence that LGE has a strong prognostic impact in thalassemic patients, warranting a close clinical and instrumental follow-up.

This abstract and the presentation materials are available to members only; a login is required.

Join Here